Sequential maintenance treatment with glatiramer acetate after mitoxantrone is safe and can limit exposure to immunosuppression in very active, relapsing remitting multiple sclerosis Sequential maintenance treatment with glatiramer acetate after mitoxantrone is safe and can limit exposure to immunosuppression in very active, relapsing remitting multiple sclerosis2018-01-17T17:02:30-05:00
Copaxone’s effect on MRI-monitored disease in relapsing MS is reproducible and sustained Copaxone’s effect on MRI-monitored disease in relapsing MS is reproducible and sustained2018-01-17T17:02:24-05:00
Modafinil Is Safe and Effective Treatment for MS-Related Fatigue Modafinil Is Safe and Effective Treatment for MS-Related Fatigue2018-01-17T17:02:18-05:00
Liver injury associated with the B-interferons for MS Liver injury associated with the B-interferons for MS2018-01-17T17:02:05-05:00
The Lessons of Vioxx — Drug Safety and Sales The Lessons of Vioxx — Drug Safety and Sales2018-01-17T17:02:05-05:00
Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue2018-01-17T17:02:05-05:00
Randomized, comparative study of interferon B-1a treatment regimens in MS Randomized, comparative study of interferon B-1a treatment regimens in MS2018-01-17T17:01:59-05:00
Severe anaphylactic reaction to glatiramer acetate with specific IgE Severe anaphylactic reaction to glatiramer acetate with specific IgE2018-01-17T17:01:59-05:00
